These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 17604654

  • 1. Pregabalin as add-on therapy for refractory partial seizures in every day clinical practice.
    Carreño M, Maestro I, Molins A, Donaire A, Falip M, Becerra JL, Castillo J.
    Seizure; 2007 Dec; 16(8):709-12. PubMed ID: 17604654
    [Abstract] [Full Text] [Related]

  • 2. Pregabalin add-on therapy using a flexible, optimized dose schedule in refractory partial epilepsies: a double-blind, randomized, placebo-controlled, multicenter trial.
    Lee BI, Yi S, Hong SB, Kim MK, Lee SA, Lee SK, Shin DJ, Kim JM, Song HK, Heo K, Lowe W, Leon T.
    Epilepsia; 2009 Mar; 50(3):464-74. PubMed ID: 19222545
    [Abstract] [Full Text] [Related]

  • 3. Pregabalin as adjunctive therapy for partial epilepsy: an audit study in 96 patients from the South East of England.
    Valentin A, Moran N, Hadden R, Oakes A, Elwes R, Delamont R, Mullatti N, Nashef L.
    Seizure; 2009 Jul; 18(6):450-2. PubMed ID: 19213577
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prospective audits with newer antiepileptic drugs in focal epilepsy: insights into population responses?
    Brodie MJ, Kelly K, Stephen LJ.
    Epilepsy Behav; 2014 Feb; 31():73-6. PubMed ID: 24361766
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures.
    Arroyo S, Anhut H, Kugler AR, Lee CM, Knapp LE, Garofalo EA, Messmer S, Pregabalin 1008-011 International Study Group.
    Epilepsia; 2004 Jan; 45(1):20-7. PubMed ID: 14692903
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. An open-label, add-on study of pregabalin in patients with partial seizures: a multicenter trial in Greece.
    Tsounis S, Kimiskidis VK, Kazis D, Gkiatas K, Garganis K, Karageorgiou K, Giannakodimos S, Papathanasopoulos P, Plaitakis A, Papadimitriou A, Lyras L, Emir B.
    Seizure; 2011 Nov; 20(9):701-5. PubMed ID: 21775167
    [Abstract] [Full Text] [Related]

  • 16. Adjunctive lacosamide in clinical practice: sodium blockade with a difference?
    Stephen LJ, Kelly K, Parker P, Brodie MJ.
    Epilepsy Behav; 2011 Nov; 22(3):499-504. PubMed ID: 21890421
    [Abstract] [Full Text] [Related]

  • 17. Exposure-response analysis of pregabalin add-on treatment of patients with refractory partial seizures.
    Miller R, Frame B, Corrigan B, Burger P, Bockbrader H, Garofalo E, Lalonde R.
    Clin Pharmacol Ther; 2003 Jun; 73(6):491-505. PubMed ID: 12811359
    [Abstract] [Full Text] [Related]

  • 18. Pregabalin: a new antiepileptic drug for refractory epilepsy.
    Hamandi K, Sander JW.
    Seizure; 2006 Mar; 15(2):73-8. PubMed ID: 16413993
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.